1-[4-[2-(2,1,3-benzoxadiazol-5-yl)ethyl]piperazin-1-yl]-2-[5-(1,2,4-triazol-1-yl)-2-pyridinyl]ethanone;3-methyl-6-[2-[4-[2-[4-(1,2,4-triazol-1-yl)phenyl]acetyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one;6-[2-[4-[5-(1,2,4-triazol-1-yl)-2,3-dihydro-1H-indene-1-carbonyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one;6-[2-[4-[2-[4-(1,2,4-triazol-1-yl)phenyl]acetyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one

C99H107N23O11 — CID 158135768

IUPAC1-[4-[2-(2,1,3-benzoxadiazol-5-yl)ethyl]piperazin-1-yl]-2-[5-(1,2,4-triazol-1-yl)-2-pyridinyl]ethanone;3-methyl-6-[2-[4-[2-[4-(1,2,4-triazol-1-yl)phenyl]acetyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one;6-[2-[4-[5-(1,2,4-triazol-1-yl)-2,3-dihydro-1H-indene-1-carbonyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one;6-[2-[4-[2-[4-(1,2,4-triazol-1-yl)phenyl]acetyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one
SMILESCC1Cc2cc(CCN3CCN(C(=O)Cc4ccc(-n5cncn5)cc4)CC3)ccc2C(=O)O1.O=C(Cc1ccc(-n2cncn2)cn1)N1CCN(CCc2ccc3nonc3c2)CC1.O=C1OCCc2cc(CCN3CCN(C(=O)C4CCc5cc(-n6cncn6)ccc54)CC3)ccc21.O=C1OCCc2cc(CCN3CCN(C(=O)Cc4ccc(-n5cncn5)cc4)CC3)ccc21
InChIInChI=1S/C27H29N5O3.C26H29N5O3.C25H27N5O3.C21H22N8O2/c33-26(25-5-2-20-16-22(3-6-23(20)25)32-18-28-17-29-32)31-12-10-30(11-13-31)9-7-19-1-4-24-21(15-19)8-14-35-27(24)34;1-19-14-22-15-21(4-7-24(22)26(33)34-19)8-9-29-10-12-30(13-11-29)25(32)16-20-2-5-23(6-3-20)31-18-27-17-28-31;31-24(16-19-1-4-22(5-2-19)30-18-26-17-27-30)29-12-10-28(11-13-29)9-7-20-3-6-23-21(15-20)8-14-33-25(23)32;30-21(12-17-2-3-18(13-23-17)29-15-22-14-24-29)28-9-7-27(8-10-28)6-5-16-1-4-19-20(11-16)26-31-25-19/h1,3-4,6,15-18,25H,2,5,7-14H2;2-7,15,17-19H,8-14,16H2,1H3;1-6,15,17-18H,7-14,16H2;1-4,11,13-15H,5-10,12H2
InChIKeyFTIDCYVXEADHBK-UHFFFAOYSA-N
MW1795.09 g/mol
LogP7.73
Rot. Bonds23

About 1-[4-[2-(2,1,3-benzoxadiazol-5-yl)ethyl]piperazin-1-yl]-2-[5-(1,2,4-triazol-1-yl)-2-pyridinyl]ethanone;3-methyl-6-[2-[4-[2-[4-(1,2,4-triazol-1-yl)phenyl]acetyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one;6-[2-[4-[5-(1,2,4-triazol-1-yl)-2,3-dihydro-1H-indene-1-carbonyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one;6-[2-[4-[2-[4-(1,2,4-triazol-1-yl)phenyl]acetyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one

1-[4-[2-(2,1,3-benzoxadiazol-5-yl)ethyl]piperazin-1-yl]-2-[5-(1,2,4-triazol-1-yl)-2-pyridinyl]ethanone;3-methyl-6-[2-[4-[2-[4-(1,2,4-triazol-1-yl)phenyl]acetyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one;6-[2-[4-[5-(1,2,4-triazol-1-yl)-2,3-dihydro-1H-indene-1-carbonyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one;6-[2-[4-[2-[4-(1,2,4-triazol-1-yl)phenyl]acetyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one (PubChem CID 158135768) has the molecular formula C99H107N23O11 and a molecular weight of 1795.09 g/mol. Its IUPAC name is 1-[4-[2-(2,1,3-benzoxadiazol-5-yl)ethyl]piperazin-1-yl]-2-[5-(1,2,4-triazol-1-yl)-2-pyridinyl]ethanone;3-methyl-6-[2-[4-[2-[4-(1,2,4-triazol-1-yl)phenyl]acetyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one;6-[2-[4-[5-(1,2,4-triazol-1-yl)-2,3-dihydro-1H-indene-1-carbonyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one;6-[2-[4-[2-[4-(1,2,4-triazol-1-yl)phenyl]acetyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one.

Molecular Properties

Compound Name1-[4-[2-(2,1,3-benzoxadiazol-5-yl)ethyl]piperazin-1-yl]-2-[5-(1,2,4-triazol-1-yl)-2-pyridinyl]ethanone;3-methyl-6-[2-[4-[2-[4-(1,2,4-triazol-1-yl)phenyl]acetyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one;6-[2-[4-[5-(1,2,4-triazol-1-yl)-2,3-dihydro-1H-indene-1-carbonyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one;6-[2-[4-[2-[4-(1,2,4-triazol-1-yl)phenyl]acetyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one
PubChem CID158135768
Molecular FormulaC99H107N23O11
Molecular Weight1795.09 g/mol
Exact Mass1793.85
IUPAC Name1-[4-[2-(2,1,3-benzoxadiazol-5-yl)ethyl]piperazin-1-yl]-2-[5-(1,2,4-triazol-1-yl)-2-pyridinyl]ethanone;3-methyl-6-[2-[4-[2-[4-(1,2,4-triazol-1-yl)phenyl]acetyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one;6-[2-[4-[5-(1,2,4-triazol-1-yl)-2,3-dihydro-1H-indene-1-carbonyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one;6-[2-[4-[2-[4-(1,2,4-triazol-1-yl)phenyl]acetyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one
SMILESCC1Cc2cc(CCN3CCN(C(=O)Cc4ccc(-n5cncn5)cc4)CC3)ccc2C(=O)O1.O=C(Cc1ccc(-n2cncn2)cn1)N1CCN(CCc2ccc3nonc3c2)CC1.O=C1OCCc2cc(CCN3CCN(C(=O)C4CCc5cc(-n6cncn6)ccc54)CC3)ccc21.O=C1OCCc2cc(CCN3CCN(C(=O)Cc4ccc(-n5cncn5)cc4)CC3)ccc21
InChIInChI=1S/C27H29N5O3.C26H29N5O3.C25H27N5O3.C21H22N8O2/c33-26(25-5-2-20-16-22(3-6-23(20)25)32-18-28-17-29-32)31-12-10-30(11-13-31)9-7-19-1-4-24-21(15-19)8-14-35-27(24)34;1-19-14-22-15-21(4-7-24(22)26(33)34-19)8-9-29-10-12-30(13-11-29)25(32)16-20-2-5-23(6-3-20)31-18-27-17-28-31;31-24(16-19-1-4-22(5-2-19)30-18-26-17-27-30)29-12-10-28(11-13-29)9-7-20-3-6-23-21(15-20)8-14-33-25(23)32;30-21(12-17-2-3-18(13-23-17)29-15-22-14-24-29)28-9-7-27(8-10-28)6-5-16-1-4-19-20(11-16)26-31-25-19/h1,3-4,6,15-18,25H,2,5,7-14H2;2-7,15,17-19H,8-14,16H2,1H3;1-6,15,17-18H,7-14,16H2;1-4,11,13-15H,5-10,12H2
InChIKeyFTIDCYVXEADHBK-UHFFFAOYSA-N
XLogP7.73
TPSA347.75 Ų
H-Bond Donors
H-Bond Acceptors30
Rotatable Bonds23
Heavy Atoms133
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001795.09
LogP ≤ 57.73
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1030

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}

Analyze 1-[4-[2-(2,1,3-benzoxadiazol-5-yl)ethyl]piperazin-1-yl]-2-[5-(1,2,4-triazol-1-yl)-2-pyridinyl]ethanone;3-methyl-6-[2-[4-[2-[4-(1,2,4-triazol-1-yl)phenyl]acetyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one;6-[2-[4-[5-(1,2,4-triazol-1-yl)-2,3-dihydro-1H-indene-1-carbonyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one;6-[2-[4-[2-[4-(1,2,4-triazol-1-yl)phenyl]acetyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[4-[2-(2,1,3-benzoxadiazol-5-yl)ethyl]piperazin-1-yl]-2-[5-(1,2,4-triazol-1-yl)-2-pyridinyl]ethanone;3-methyl-6-[2-[4-[2-[4-(1,2,4-triazol-1-yl)phenyl]acetyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one;6-[2-[4-[5-(1,2,4-triazol-1-yl)-2,3-dihydro-1H-indene-1-carbonyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one;6-[2-[4-[2-[4-(1,2,4-triazol-1-yl)phenyl]acetyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one?
The IUPAC name of 1-[4-[2-(2,1,3-benzoxadiazol-5-yl)ethyl]piperazin-1-yl]-2-[5-(1,2,4-triazol-1-yl)-2-pyridinyl]ethanone;3-methyl-6-[2-[4-[2-[4-(1,2,4-triazol-1-yl)phenyl]acetyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one;6-[2-[4-[5-(1,2,4-triazol-1-yl)-2,3-dihydro-1H-indene-1-carbonyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one;6-[2-[4-[2-[4-(1,2,4-triazol-1-yl)phenyl]acetyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one (CID 158135768) is 1-[4-[2-(2,1,3-benzoxadiazol-5-yl)ethyl]piperazin-1-yl]-2-[5-(1,2,4-triazol-1-yl)-2-pyridinyl]ethanone;3-methyl-6-[2-[4-[2-[4-(1,2,4-triazol-1-yl)phenyl]acetyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one;6-[2-[4-[5-(1,2,4-triazol-1-yl)-2,3-dihydro-1H-indene-1-carbonyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one;6-[2-[4-[2-[4-(1,2,4-triazol-1-yl)phenyl]acetyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one.
What is the SMILES notation for 1-[4-[2-(2,1,3-benzoxadiazol-5-yl)ethyl]piperazin-1-yl]-2-[5-(1,2,4-triazol-1-yl)-2-pyridinyl]ethanone;3-methyl-6-[2-[4-[2-[4-(1,2,4-triazol-1-yl)phenyl]acetyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one;6-[2-[4-[5-(1,2,4-triazol-1-yl)-2,3-dihydro-1H-indene-1-carbonyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one;6-[2-[4-[2-[4-(1,2,4-triazol-1-yl)phenyl]acetyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one?
The canonical SMILES for 1-[4-[2-(2,1,3-benzoxadiazol-5-yl)ethyl]piperazin-1-yl]-2-[5-(1,2,4-triazol-1-yl)-2-pyridinyl]ethanone;3-methyl-6-[2-[4-[2-[4-(1,2,4-triazol-1-yl)phenyl]acetyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one;6-[2-[4-[5-(1,2,4-triazol-1-yl)-2,3-dihydro-1H-indene-1-carbonyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one;6-[2-[4-[2-[4-(1,2,4-triazol-1-yl)phenyl]acetyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one is CC1Cc2cc(CCN3CCN(C(=O)Cc4ccc(-n5cncn5)cc4)CC3)ccc2C(=O)O1.O=C(Cc1ccc(-n2cncn2)cn1)N1CCN(CCc2ccc3nonc3c2)CC1.O=C1OCCc2cc(CCN3CCN(C(=O)C4CCc5cc(-n6cncn6)ccc54)CC3)ccc21.O=C1OCCc2cc(CCN3CCN(C(=O)Cc4ccc(-n5cncn5)cc4)CC3)ccc21.
What is the InChIKey of 1-[4-[2-(2,1,3-benzoxadiazol-5-yl)ethyl]piperazin-1-yl]-2-[5-(1,2,4-triazol-1-yl)-2-pyridinyl]ethanone;3-methyl-6-[2-[4-[2-[4-(1,2,4-triazol-1-yl)phenyl]acetyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one;6-[2-[4-[5-(1,2,4-triazol-1-yl)-2,3-dihydro-1H-indene-1-carbonyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one;6-[2-[4-[2-[4-(1,2,4-triazol-1-yl)phenyl]acetyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one?
The InChIKey is FTIDCYVXEADHBK-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H29N5O3.C26H29N5O3.C25H27N5O3.C21H22N8O2/c33-26(25-5-2-20-16-22(3-6-23(20)25)32-18-28-17-29-32)31-12-10-30(11-13-31)9-7-19-1-4-24-21(15-19)8-14-35-27(24)34;1-19-14-22-15-21(4-7-24(22)26(33)34-19)8-9-29-10-12-30(13-11-29)25(32)16-20-2-5-23(6-3-20)31-18-27-17-28-31;31-24(16-19-1-4-22(5-2-19)30-18-26-17-27-30)29-12-10-28(11-13-29)9-7-20-3-6-23-21(15-20)8-14-33-25(23)32;30-21(12-17-2-3-18(13-23-17)29-15-22-14-24-29)28-9-7-27(8-10-28)6-5-16-1-4-19-20(11-16)26-31-25-19/h1,3-4,6,15-18,25H,2,5,7-14H2;2-7,15,17-19H,8-14,16H2,1H3;1-6,15,17-18H,7-14,16H2;1-4,11,13-15H,5-10,12H2.
What are the key properties of 1-[4-[2-(2,1,3-benzoxadiazol-5-yl)ethyl]piperazin-1-yl]-2-[5-(1,2,4-triazol-1-yl)-2-pyridinyl]ethanone;3-methyl-6-[2-[4-[2-[4-(1,2,4-triazol-1-yl)phenyl]acetyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one;6-[2-[4-[5-(1,2,4-triazol-1-yl)-2,3-dihydro-1H-indene-1-carbonyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one;6-[2-[4-[2-[4-(1,2,4-triazol-1-yl)phenyl]acetyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one?
1-[4-[2-(2,1,3-benzoxadiazol-5-yl)ethyl]piperazin-1-yl]-2-[5-(1,2,4-triazol-1-yl)-2-pyridinyl]ethanone;3-methyl-6-[2-[4-[2-[4-(1,2,4-triazol-1-yl)phenyl]acetyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one;6-[2-[4-[5-(1,2,4-triazol-1-yl)-2,3-dihydro-1H-indene-1-carbonyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one;6-[2-[4-[2-[4-(1,2,4-triazol-1-yl)phenyl]acetyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one has a molecular weight of 1795.09 g/mol, XLogP of 7.73, 23 rotatable bonds, 0 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[4-[2-(2,1,3-benzoxadiazol-5-yl)ethyl]piperazin-1-yl]-2-[5-(1,2,4-triazol-1-yl)-2-pyridinyl]ethanone;3-methyl-6-[2-[4-[2-[4-(1,2,4-triazol-1-yl)phenyl]acetyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one;6-[2-[4-[5-(1,2,4-triazol-1-yl)-2,3-dihydro-1H-indene-1-carbonyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one;6-[2-[4-[2-[4-(1,2,4-triazol-1-yl)phenyl]acetyl]piperazin-1-yl]ethyl]-3,4-dihydroisochromen-1-one is sourced from PubChem (CID 158135768), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).